MedTrace Logo

Clinical Study on Treatment of Chronic Persistent Bronchial Asthma

NCT03228134 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 320

Last updated 2023-05-25

No results posted yet for this study

Summary

Investigators aimed to evaluate the clinical efficacy of integrated traditional Chinese and Western medicine in the treatment of asthma, and to further optimize the prescription of Chinese medicine treatment.

Conditions

  • Bronchial Asthma

Interventions

DRUG

Ke Chuan Liu Wei Granule

Traditional Chinese Medicine

DRUG

Yang He Ping Chuan Granule

Traditional Chinese Medicine

OTHER

Ke Chuan Liu Wei Granule placebo

Placebo

OTHER

Yang He Ping Chuan Granule placebo

Placebo

Sponsors & Collaborators

  • Longhua Hospital

    collaborator OTHER

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-01
Primary Completion
2024-09-30
Completion
2024-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03228134 on ClinicalTrials.gov